https://multiplesclerosisnewstoday.com/wp-content/uploads/videos/Dr-Warren-Olanow.mp4 Parkinson’s News Today correspondent conducts an exclusive interview with Dr. Warren Olanow, M.D., Clinical Advisory Board of Cynapsus. Follow our live coverage of #CONy16 on Twitter and here: https://bit.ly/1Vjl1D8…

https://multiplesclerosisnewstoday.com/wp-content/uploads/videos/Sequence-02.mp4 Parkinson’s News Today correspondent conducts an exclusive interview with Professor Amos Korczyn, CONy’s 2016 Co-Chairperson. Read more recent news: https://bit.ly/1VurFXd…

Multinational research-based biopharmaceutical company AbbVie‘s product DUOPA is a fresh approach to the administration of carbidopa and levodopa for the treatment of motor fluctuations that afflict people with advanced Parkinson’s disease. A researcher, in an exclusive interview with Parkinson’s News Today at the recent  10th World Congress on…

That the formation of alpha-synuclein aggregates, formed by misfolded forms of the protein, is somehow linked to Parkinson’s disease development is a fact few would dispute. Whether preventing the formation, or increasing the clearance of these protein masses, possibly by vaccination, as a viable approach to treatment is, however, a…

Cynapsus Therapeutics, currently conducting a pivotal Phase 3 clinical study of its sublingual formulation of apomorphine to treat “OFF” episodes in Parkinson’s disease (PD), is teaming up with the Michael J. Fox Foundation for Parkinson’s Research (MJFF) for a sub-study that will use wearable technology to gather and analyze…

The 10th World Congress on Controversies in Neurology (CONy), now taking place in Lisbon, Portugal, is hosting international experts in the field, and serving as a platform for the comparison of experimental clinical and basic data in a range of diseases. The congress also offers the opportunity for debate on unresolved scientific issues. Research into…

The 10th World Congress on Controversies in Neurology (CONy), a leading venue for researchers, clinicians, and industry leaders to discuss everything from the latest advances to unresolved issues in the field, will meet this week, March 17-20, at the Sana Lisboa Hotel in Lisbon, Portugal.